-
Product Insights
NewcAMP Specific 3′,5′ Cyclic Phosphodiesterase 4B – Drugs In Development, 2024
The cAMP Specific 3',5' Cyclic Phosphodiesterase 4B pipeline drugs market research report outlays comprehensive information on the cAMP Specific 3',5' Cyclic Phosphodiesterase 4B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Musculoskeletal Disorders, and Immunology which include indications of Respiratory, Asthma, Schizophrenia, Unspecified Neurologic Disorders, Psoriatic Arthritis, Plaque Psoriasis (Psoriasis Vulgaris), and Palmoplantar...
-
Product Insights
NewSerine/Threonine Protein Kinase Pim 3 – Drugs In Development, 2024
The Serine/Threonine Protein Kinase Pim 3 pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Pim 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Gastrointestinal which include indications of Hematological Tumor, Chronic Lymphocytic Leukemia (CLL), Psoriasis, Rheumatoid Arthritis, and Inflammatory Bowel Disease. It also reviews key players involved in...
-
Product Insights
NewInterleukin 17F – Drugs In Development, 2024
The Interleukin 17F pipeline drugs market research report outlays comprehensive information on the Interleukin 17F targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Musculoskeletal Disorders, Dermatology, and Undisclosed which include indications of Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis, Ankylosing Spondylitis (Bekhterev's Disease), Psoriatic Arthritis, Hidradenitis Suppurativa, Atopic Dermatitis (Atopic Eczema), and Unspecified. It also reviews key players...
-
Product Insights
NewC-X-C Chemokine Receptor Type 1 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Metastatic Colorectal Cancer, Solid Tumor, Psoriasis, Inflammation, Obesity, Type 1 Diabetes (Juvenile Diabetes), and Hidradenitis Suppurativa. It also...
-
Product Insights
NewIntermediate Conductance Calcium Activated Potassium Channel Protein 4 – Drugs In Development, 2024
The Intermediate Conductance Calcium Activated Potassium Channel Protein 4 pipeline drugs market research report outlays comprehensive information on the Intermediate Conductance Calcium Activated Potassium Channel Protein 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Respiratory, Immunology, and Musculoskeletal Disorders which include indications of Cardiovascular, Arrhythmias, Idiopathic Pulmonary Fibrosis, Asthma, Psoriasis, Autoimmune Disorders, Rheumatic Disorders, and...
-
Product Insights
NewInterleukin 1 Receptor Like 2 – Drugs In Development, 2024
The Interleukin 1 Receptor Like 2 pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Receptor Like 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Dermatology, Gastrointestinal, and Respiratory which include indications of Generalized Pustular Psoriasis (GPP), Psoriasis, Hidradenitis Suppurativa, Dermatology, Ulcerative Colitis, Inflammatory Bowel Disease, and Idiopathic Pulmonary Fibrosis. It also...
-
Product Insights
NewSerine/Threonine Protein Kinase Pim 2 – Drugs In Development, 2024
The Serine/Threonine Protein Kinase Pim 2 pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Pim 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Gastrointestinal which include indications of Hematological Tumor, Oncology, Psoriasis, Rheumatoid Arthritis, and Inflammatory Bowel Disease. It also reviews key players involved in Serine/Threonine Protein Kinase...
-
Product Insights
NewCytosolic Phospholipase A2 – Drugs In Development, 2024
The Cytosolic Phospholipase A2 pipeline drugs market research report outlays comprehensive information on the Cytosolic Phospholipase A2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Immunology, and Genito Urinary System which include indications of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), Breast Cancer, Leukemia, Plaque Psoriasis (Psoriasis Vulgaris), Inflammation, Kidney Fibrosis,...
-
Product Insights
NewV Type Immunoglobulin Domain Containing Suppressor of T Cell Activation – Drugs In Development, 2024
The V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation pipeline drugs market research report outlays comprehensive information on the V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Central Nervous System which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Psoriasis, Autoimmune...
-
Product Insights
NewProteinase Activated Receptor 2 – Drugs In Development, 2024
The Proteinase Activated Receptor 2 pipeline drugs market research report outlays comprehensive information on the Proteinase Activated Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Gastrointestinal, and Immunology which include indications of Asthma, Unspecified Respiratory Disorders, Migraine, Unspecified Neurologic Disorders, Inflammatory Bowel Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Psoriasis, and Unspecified Immunological...